阿斯普利尼亚
脾脏
脾切除术
免疫学
医学
肺炎链球菌
免疫系统
接种疫苗
脑膜炎奈瑟菌
抗生素
生物
微生物学
细菌
遗传学
作者
Marco Vincenzo Lenti,Sarah Luu,Rita Carsetti,Faith Osier,Rodney Ogwang,Obiageli Nnodu,Ursula Wiedermann,Jo Spencer,Franco Locatelli,Gino Roberto Corazza,Antonio Di Sabatino
标识
DOI:10.1038/s41572-022-00399-x
摘要
Asplenia (the congenital or acquired absence of the spleen) and hyposplenism (defective spleen function) are common causes of morbidity and mortality. The spleen is a secondary lymphoid organ that is responsible for the regulation of immune responses and blood filtration. Hence, asplenia or hyposplenism increases susceptibility to severe and invasive infections, especially those sustained by encapsulated bacteria (namely, Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b). Asplenia is predominantly due to splenectomy for either traumatic events or oncohaematological conditions. Hyposplenism can be caused by several conditions, including haematological, infectious, autoimmune and gastrointestinal disorders. Anatomical disruption of the spleen and depletion of immune cells, especially IgM memory B cells, seem to be predominantly responsible for the clinical manifestations. Early recognition of hyposplenism and proper management of asplenia are warranted to prevent overwhelming post-splenectomy infections through vaccination and antibiotic prophylaxis. Although recommendations are available, the implementation of vaccination strategies, including more effective and immunogenic vaccines, is needed. Additionally, screening programmes for early detection of hyposplenism in high-risk patients and improvement of patient education are warranted. Asplenia and hyposplenism can have multiple and complex causes and lead to morbidity and mortality, especially owing to overwhelming post-splenectomy infections. In this Primer, Lenti and colleagues review epidemiology, pathophysiology, diagnosis and management of these conditions, and discuss patient quality of life and future strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI